# Op-Ed | New York needs to get THC beverages right | amNewYork > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/op-ed-new-york-needs-to-get-thc-beverages-right-amnewyork/ > **Published:** 2026-08-18T12:25:01-04:00 | **Last Modified / Clinically Audited:** 2026-09-08T20:16:14-04:00 > **Clinical Summary:** THC beverages dosing safety clinical guide. Onset time, potency concerns, and patient counseling for clinicians. --- โœฆ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCSafetyPolicyDosingIndustryMental HealthAnxiety Why This Matters Clinicians need to understand THC beverage risks because patients may not recognize them as cannabis products or may underestimate dosing compared to other consumption methods, leading to delayed onset of effects and accidental overdose. As THC beverages become more available in regulated markets, clinicians should counsel patients on dose standardization, onset timing, and interactions with medications and alcohol, particularly given the appeal of these products to patients unfamiliar with cannabis. Clinical Summary THC-infused beverages represent a rapidly expanding cannabis product category in states like New York where recreational use is legal, introducing new considerations for clinicians counseling patients about cannabis consumption. Unlike traditional smoked or edible cannabis products, beverages present distinct pharmacokinetic profiles, dosing consistency challenges, and packaging concerns that affect both therapeutic efficacy and safety. The growing popularity of THC drinks among consumers, particularly younger populations unfamiliar with cannabis effects, increases the clinical relevance of understanding absorption rates, onset of action, and the potential for accidental overdose or misuse compared to more conventional cannabis forms. Regulatory frameworks governing THC beverage potency, labeling, and marketing will directly influence the risk profile patients encounter and the information available to guide clinical counseling. Clinicians should familiarize themselves with the specific characteristics of THC beverages, including their variable absorption and delayed peak effects, to provide informed guidance on dosing, timing of consumption, and potential drug interactions. Clear understanding of how THC beverages compare to other cannabis [delivery methods](https://cedclinic.com/state-ban-smokable-cannabis-impact-central-texas/) will help clinicians better counsel patients on safe and effective use for both medical and recreational purposes. Clinical Perspective ๐Ÿท The expansion of THC-infused beverages into mainstream markets presents clinicians with both opportunities and challenges in [patient counseling](https://cedclinic.com/stroke-risk-assessment-substance-use/) and [harm reduction](https://cedclinic.com/can-you-mix-weed-and-alcohol/). While standardized beverage formats may offer more predictable dosing compared to other cannabis products, the palatability and social acceptability of these drinks could increase consumption frequency and appeal to populations less familiar with cannabis effects, potentially masking the intoxicating impact of THC. Regulatory gaps around labeling clarity, serving size definitions, and distinction from non-intoxicating [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) create confusion that extends to clinical settings, where patients may underestimate their intake or fail to disclose consumption during history-taking. Clinicians should proactively ask about THC beverage use during substance screening, educate patients about delayed onset effects (which differ from smoked cannabis), and remain alert to [impaired driving](https://cedclinic.com/cannabis-impairment-detection-driving-safety/) risk and potential drug interactions, particularly in older adults or those on CYP3A4- ๐Ÿ’ฌ Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan โ†’](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion โ†’](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Op-Ed%20%7C%20New%20York%20needs%20to%20get%20THC%20beverages%20right%20%7C%20amNewYork%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74304)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74304)[๐Ÿฆ… Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Op-Ed%20%7C%20New%20York%20needs%20to%20get%20THC%20beverages%20right%20%7C%20amNewYork%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D74304)[๐Ÿ“ท Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[๐Ÿ“ Read more on Substack](https://doctorapprovedcannabis.substack.com/)[๐Ÿ”” Subscribe via RSS](https://cedclinic.com/feed/) ๐Ÿ“ฐ Source: [https://www.amny.com/opinion/new-york-thc-beverages/](https://www.amny.com/opinion/new-york-thc-beverages/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR ยง 164.514(b)) and criteria for secondary research exemption under 45 CFR ยง 46.104(d)(4).